Preventing postsurgical relapse of Crohn's disease: can we do better?

January 2009
Gut;Jan2009, Vol. 58 Issue 1, p126
Academic Journal
The article presents author's view on the study on the effectiveness of the therapy to prevent postoperative recurrence of Crohn's disease. The author relates that the primary outcome of endoscopic neoterminal ileal recurrence was observed in 55% on azathioprine or placebo for 12 months. Results suggest that early and aggressive intervention can reduce recurrence of Crohn's disease following ileocaecal resection and should be considered in patients deemed to be at high risk.


Related Articles

  • Cyclosporine and 6-Mercaptopurine for Active, Refractory Crohn's Colitis in Children. Mahdi, Gamal; Israel, David M.; Hassall, Eric // American Journal of Gastroenterology;Jul1996, Vol. 91 Issue 7, p1355 

    Objectives: This prospective, open trial of treatment was conducted to determine whether cyclosporine A (CSA) is effective in inducing remission in children with severe, active Crohn's colitis refractory to other medical treatment and if remission may be maintained by 6-mercaptopurine (6-MP) and...

  • Biological Therapy for the Prevention and Treatment of Postoperative Endoscopic Recurrence in Crohn's Disease: Time for Acceptance? Kotze, Paulo Gustavo; Saad-Hossne, RogĂ©rio // Intestinal Research;2013, Vol. 11 Issue 4, p256 

    worldIn most patients, postoperative endoscopic recurrence (PER) occurs 1 year after abdominal resection for Crohn's disease (CD). Preventing PER is essential for disease control, as most patients develop further clinical and surgical recurrences. Conventional therapy with nitroimidazoles,...

  • Enterovesical Fistula Complicating Crohn's Ileocolitis. Schraut, Wolfgang H.; Block, George E. // American Journal of Gastroenterology;Mar1984, Vol. 79 Issue 3, p186 

    An enterovesical fistula, an infrequent complication of Crohn's ileocolitis which is considered to constitute a difficult surgical problem, was encountered in 29 patients. These patients had been treated for Crohn's disease by medical means for years and several had previously undergone bowel...

  • GENETIC ANTICIPATION IN CROHN'S DISEASE. Bayless, Theodore M.; Picco, Michael F.; LaBuda, Michele C. // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2322 

    Discusses research being done on genetic anticipation in Crohn's disease. Reference to a study led by D. Heresbach, B. Gulwani-Akolkar and M. Lesser, which appeared in the 1998 issue of the "American Journal of Gastroenterology"; Potential biases that could influence the age at a diagnosis in...

  • Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease. Luthra, Gurinder; Pasricha, P. Jay // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p92 

    Comments on a study which discovered that olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis. Comparison of the effects of olsalazine and placebo on patients; Assessment of adverse events in patients; Effects of mesalamine on patients.

  • 'Placebos Are Getting More Effective.'. Klotter, Jule // Townsend Letter;Feb/Mar2010, Issue 319/320, p37 

    The article focuses on the placebo effect and its role in clinical trials. It says that despite not having active chemical ingredients, the response of people to placebos during clinical trials appears to be strengthening. It relates the case of Osiris Therapeutics which decided to withdraw a...

  • IS IT BEST TO GIVE BUDESONIDE FOR ACUTE FLARES OF CROHN'S DISEASE?  // Pulse;12/17/2005, Vol. 65 Issue 49, p32 

    The article presents information on the role played by budesonide, a steroid in active Crohn's disease. Steroids have significant adverse effects when used repeatedly or for extended periods. The article evaluates the effectiveness of oral budesonide and the adverse effect profile. Several...

  • Placebo: Misunderstandings and Prejudices. Breidert, Matthias; Hofbauer, Karl // Deutsches Aerzteblatt International;11/13/2009, Vol. 106 Issue 46, p8 

    The article offers information on the history, definition and efficacy of the placebo medicine. The word "placebo" originates from the Latin word "placere," which means "I shall please." According to the classical definition, a placebo is a drug without any pharmacologically active substance....

  • Methotrexate effective for maintenance of remission in Crohn's disease. McAvoy, Brian R. // New Zealand Doctor;3/10/2010, p28 

    The article presents a study that examined the effectiveness of methotrexate for maintenance of remission in Crohn's disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics